Report Reveals the Digital Divide in CDMO Manufacturing
Digital transformation is rapidly shifting from competitive advantage to market requirement for contract manufacturing and development organizations (CDMOs) in life sciences. While 92% of life sciences CDMOs report sponsors now discussing digital capabilities in negotiations, 60% still operate at preliminary digital maturity levels. This comprehensive survey of 50-plus global CDMOs reveals the stark reality: the window for digital readiness is closing.
Discover where your organization stands in the era of digital manufacturing. This exclusive report exposes the brutal economics of CDMO manufacturing, revealing which CDMOs are winning with strategic artificial intelligence (AI) deployment and which are falling behind. Learn how digital manufacturing leaders are overcoming implementation barriers while laggards struggle with legacy infrastructure and resource constraints.
Download this data-driven report to understand the competitive landscape and position your CDMO for success in an increasingly digital marketplace.
For CDMOs in life sciences, digital manufacturing is no longer just a competitive advantage—it's now a market requirement. As sponsors increasingly demand real-time visibility, integrated quality systems, and data-driven insights, CDMOs face mounting pressure to modernize operations beyond century-old paper-based processes.
The survey data reveals a sobering reality: while 83% of life sciences CDMOs pursue digitization for productivity and efficiency improvements, only 27% have implemented electronic batch records and just 25% use manufacturing execution systems. This gap between ambition and execution creates both risk and opportunity. Leading organizations are achieving enterprise-level integration through strategic connectivity of quality management systems (QMS), learning information management systems (LIMS), and enterprise resource planning (ERP) platforms. Connectivity has become the core of building a foundation for AI-powered manufacturing intelligence.
Get exclusive benchmarking data and strategic insights from 50-plus global CDMOs.
Download the ReportThis survey benchmarks digital manufacturing adoption among CDMOs in life sciences, identifying industry trends, challenges, and opportunities to help your organization navigate digital transformation effectively.
Professionals from contract development and manufacturing organizations (CDMOs) involved in operations, technology implementation, quality assurance, or executive leadership in life sciences manufacturing.
This research was conducted by MasterControl in partnership with PharmaSource, combining industry expertise to deliver actionable insights for CDMOs.
The survey addresses digital technology adoption, implementation challenges, future investment priorities, ROI measurement, regulatory considerations, and digital transformation strategies.
MasterControl's Manufacturing Excellence (Mx) solution provides life sciences CDMOs with a cloud-based platform designed to meet evolving sponsor requirements while driving operational excellence. Unite operational processes within a single intelligent system that embeds compliance directly into production workflows, accelerating market access and production efficiency.
Eliminate paper-based compliance gaps with fully digitized electronic batch records that automatically adapt to evolving regulatory requirements, ensuring CDMO manufacturing processes remain compliant with FDA and ISO standards without disrupting production operations.
Deploy AI-powered in-line checks that enforce regulatory requirements during production in real-time, reducing deviations by up to 90% while capturing comprehensive data needed to demonstrate compliance across global regulatory frameworks.
Ensure manufacturing teams always execute against current approved procedures that align with regulatory standards through intelligent document control at the production line, completely eliminating the risk of outdated work instructions or noncompliant processes.
Transform production data into actionable insights through advanced analytics that support continuous improvement initiatives while maintaining the comprehensive evidence needed for regulatory submissions, sponsor audits, and quality investigations across all markets.